T1	p 928 941	United States
T2	p 1097 1265	General surgical patients including those undergoing noncardiac thoracic and pelvic operations who were identified at moderate to high risk for postop DVT were included
T3	p 1456 1563	Eight hundred and eighty eight patients were entered into this trial and 744 ( 85 % ) completed the study .
T4	i 547 572	dihydroergotamine ( DHE )
T5	i 577 584	heparin
T6	i 982 985	DHE
T7	i 998 1005	heparin
T8	i 1015 1018	DHE
T9	i 1031 1038	heparin
T10	i 1048 1055	heparin
T11	i 1069 1072	DHE
T12	i 1087 1094	placebo
T13	i 1620 1627	DHE/Hep
T14	i 1645 1652	placebo